Braak stage 1, 100% of pigmented neurons left
parkinsonconnecting

Gene record

NKX2-2

NK2 homeobox 2

translation score 0.39, read 2026-10-28; 2 sealed predictions, 0 held; 3 receipts.

Six readers

readerfoundscore
genetics
Open Targets
no genetic evidence; overall 0.00 from other evidence0.00
cell type
Human Protein Atlas
group enriched, including oligodendrocytes; strongest in neuroendocrine cells0.75
chemistry
Open Targets
hard to drug0.00
trials
ClinicalTrials.gov
no Parkinson's trials on record: an open field1.00
literature
PubMed
9 Parkinson's papers of 7240.70
pathways
Reactome
2 pathways; mostly other0.30

No case: the score is under the bar. Receipt 13095

Sealed predictions

  1. NKX2-2 in dopamine neurons, braak+0.27 (p 0.487) → +0.33 (p 0.385)receipt 13103
  2. NKX2-2 in oligodendrocytes, braak-0.03 (p 0.946) → +0.30 (p 0.428)receipt 13102

Swarm cases

receipt 13103: NKX2-2 in dopamine neurons, braak

power
full sample +0.37 (p 0.135, n 18), 95% CI -0.12 to +0.71. the interval is wide: not enough donors to tell.
confounder
adjusted for sex: +0.40 (p 0.099, n 18). does not hold up.
composition
dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.39 (p 0.105, n 18). could be the mix.
skeptic
leave-one-out range +0.29 to +0.47, sign flips 0; without severely affected donors +0.37 (p 0.135, n 18). fragile.
cell type
no other cell group does better.
axis
no measure beats "tracks Braak Lewy-body stage" for NKX2-2 in dopamine neurons.

case closed: nothing better to follow up.

receipt 13102: NKX2-2 in oligodendrocytes, braak

power
full sample +0.04 (p 0.874, n 18), 95% CI -0.43 to +0.50. the interval is wide: not enough donors to tell.
confounder
adjusted for sex: -0.06 (p 0.814, n 18). does not hold up.
composition
oligodendrocytes share of nuclei vs axis +0.03 (p 0.915); controlling for it: -0.11 (p 0.652, n 18). could be the mix.
skeptic
leave-one-out range -0.08 to +0.16, sign flips 5; without severely affected donors +0.04 (p 0.874, n 18). fragile.
cell type
no other cell group does better.
axis
no measure beats "tracks Braak Lewy-body stage" for NKX2-2 in oligodendrocytes.

case closed: nothing better to follow up.

Receipts

loading the receipts